Teriflunomide
NDC 59651-054, Teriflunomide, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 59651-054
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209638
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-054 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERIFLUNOMIDE7 mg/1
Pharmacologic classes
Dihydroorotate Dehydrogenase Inhibitors [MoA]; Pyrimidine Synthesis Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-054-28 | 59651005428 | 2 BLISTER PACK in 1 CARTON (59651-054-28) / 14 TABLET in 1 BLISTER PACK |
| 59651-054-30 | 59651005430 | 30 TABLET in 1 BOTTLE (59651-054-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2fd80242-c607-4c50-b497-8259abb4a2f8NADAC price for package 59651005430
GET /v1/drugs/nadac/59651005430
Use it
Look up 59651-054 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-054 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-054. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.